Replies to post #942 on Eiger BioPharmaceuticals Inc (EIGRQ)

[Pink Current]

Looking good for today.....from latest 8K

Exhibit 99.1 is a press release issued by Eiger on January 6, 2016 entitled “Eiger BioPharmaceuticals Announces First Patient Dosed in Phase 2 LOWR HDV – 4 (LOnafarnib With Ritonavir in Hepatitis Delta Virus – 4) Study at Hannover Medical School in Hannover, Germany.”

http://ih.advfn.com/p.php?pid=nmona&article=69912725&symbol=CLDN

Moving right along to human trials now.

CLDN

HPT